Matches in Nanopublications for { ?s ?p "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP90302.RACiZ9Gw4XHZV2zexaeWokvNJQc9IRZHjoa2aQiHs0hdI130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90302.RACiZ9Gw4XHZV2zexaeWokvNJQc9IRZHjoa2aQiHs0hdI130_provenance.
- NP147787.RATv8ahsod36SsOp1g6axe652srcb2jGx4PhZt86a1DRg130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147787.RATv8ahsod36SsOp1g6axe652srcb2jGx4PhZt86a1DRg130_provenance.
- NP579721.RALWDVzsdA6TBhTS7CAEv3jO7ultj1iJnApqoOAkNHOko130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579721.RALWDVzsdA6TBhTS7CAEv3jO7ultj1iJnApqoOAkNHOko130_provenance.
- NP115670.RAj9TmBSsQxsS-QcDcf97L9-p_m7T2geZKMb9oO7z7INE130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115670.RAj9TmBSsQxsS-QcDcf97L9-p_m7T2geZKMb9oO7z7INE130_provenance.
- assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP186723.RACQpoSBSnOSoSD7NiLxUg97MPZXUmMYxF8vcTDPUidNY130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186723.RACQpoSBSnOSoSD7NiLxUg97MPZXUmMYxF8vcTDPUidNY130_provenance.
- assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP842568.RA_wiv0oVRXa4dtmi-xwDiOJJY9wrPWgGMWARoSa_rJkU130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842568.RA_wiv0oVRXa4dtmi-xwDiOJJY9wrPWgGMWARoSa_rJkU130_provenance.
- NP186718.RA6l89s-ED3qZy30cGSm4Otf0YE94wjvXPnl_AX7nOP0w130_assertion description "[ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186718.RA6l89s-ED3qZy30cGSm4Otf0YE94wjvXPnl_AX7nOP0w130_provenance.